Advertisement

Topics

InspireMD Company Profile

16:00 EST 18th December 2018 | BioPortfolio

InspireMD Ltd. is an innovative medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard(TM). The company intends to apply its technology to develop products used in interventional cardiology and other vascular procedures. InspireMD's mission is to utilize its proprietary technology to make its products the industry standard for stents and to provide a superior solution to the key clinical issues of current stenting: restenosis, embolic showers, and late thrombosis. In addition to providing embolic protection and minimizing arterial injury, this promising technology can be an effective and uniform drug delivery mechanism with the help of the novel micron-level net for next generation drug eluting stents. InspireMD intends to pursue applications of this technology both for bare metal and drug eluting stents in coronary, carotid and peripheral artery procedures.


News Articles [24 Associated News Articles listed on BioPortfolio]

Australia approves InspireMD's embolic prevention system

Australia's Therapeutic Goods Administration has granted InspireMD approval for commercial sale and reimbursement of its CGua -More- 

$10M public offering priced by InspireMD

An underwritten public offering of common stock and Series D warrants has been priced by InspireMD in hopes of raising approx -More- 

InspireMD Announces Issuance of Two New U.S. Patents Covering Proprietary MicroNet Stent Jacket and Related Drug Eluting Technology

InspireMD (NYSE:NSPR), developer of the CGuard Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, announced that the United States Patent a...

InspireMD opens first two CGuard EPS Centers of Excellence in Europe

The first COE is at the Augusta Hospital Clinic for Vascular Surgery in Düsseldorf, Germany and is led by Prof. Ralf Kolvenbach, Head of the Cardiovascular Diseases Department The post InspireMD ope...

InspireMD Announces Regulatory and Reimbursement Approval of CGuard Embolic Prevention System in Australia

InspireMD (NYSE American:NSPR), developer of the CGuard Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, today announced that its novel C...

InspireMD’s CGuard Product Receives Approvals in Australia

Australia's regulatory agency granted approval for the device which prevents stroke caused by the treatment of carotid artery disease. The post InspireMD’s CGuard Product Receives Approvals in A...

InspireMD Announces Third Quarter 2018 Financial Results and Provides Corporate Update

Presented Three-Year Data Highlighting Long-Term Safety and Efficacy of CGuard™ Embolic Prevention System   On-Track to Submit U.S. IDE in Mid-2019 Company to Host Investor Conference Call at...

InspireMD's (NSPR) CEO Jim Barry on Q3 2018 Results - Earnings Call Transcript

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

The Israeli MGuard Registry

the objective of the Israeli MGurad Registry is to evaluate the 'Real World' Clinical Performance of the InspireMD MGuard Coronary Stent System

Companies [2 Associated Companies listed on BioPortfolio]

InspireMD

InspireMD Ltd. is an innovative medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard(TM). The company intends to apply its te...

Inspire MD

InspireMD is an innovative medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard(TM). The company intends to apply its technol...

More Information about "InspireMD" on BioPortfolio

We have published hundreds of InspireMD news stories on BioPortfolio along with dozens of InspireMD Clinical Trials and PubMed Articles about InspireMD for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of InspireMD Companies in our database. You can also find out about relevant InspireMD Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

Stent
A stent is a small mesh tube that's used to treat narrow or weak arteries. Arteries are blood vessels that carry blood away from your heart to other parts of your body.  A stent is placed in an artery as part of a procedure called angioplasty. &...

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...


Corporate Database Quicklinks



Searches Linking to this Company Record